Literature DB >> 33303695

Mitochondria as a Novel Target for Cancer Chemoprevention: Emergence of Mitochondrial-targeting Agents.

Mofei Huang1,2, Charles R Myers1,2, Yian Wang1,2, Ming You3,2.   

Abstract

Cancer chemoprevention is the most effective approach to control cancer in the population. Despite significant progress, chemoprevention has not been widely adopted because agents that are safe tend to be less effective and those that are highly effective tend to be toxic. Thus, there is an urgent need to develop novel and effective chemopreventive agents, such as mitochondria-targeted agents, that can prevent cancer and prolong survival. Mitochondria, the central site for cellular energy production, have important functions in cell survival and death. Several studies have revealed a significant role for mitochondrial metabolism in promoting cancer development and progression, making mitochondria a promising new target for cancer prevention. Conjugating delocalized lipophilic cations, such as triphenylphosphonium cation (TPP+), to compounds of interest is an effective approach for mitochondrial targeting. The hyperpolarized tumor cell membrane and mitochondrial membrane potential allow for selective accumulation of TPP+ conjugates in tumor cell mitochondria versus those in normal cells. This could enhance direct killing of precancerous, dysplastic, and tumor cells while minimizing potential toxicities to normal cells. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33303695      PMCID: PMC8137522          DOI: 10.1158/1940-6207.CAPR-20-0425

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  184 in total

1.  Inhibitory effect of tumor cell-derived lactic acid on human T cells.

Authors:  Karin Fischer; Petra Hoffmann; Simon Voelkl; Norbert Meidenbauer; Julia Ammer; Matthias Edinger; Eva Gottfried; Sabine Schwarz; Gregor Rothe; Sabine Hoves; Kathrin Renner; Birgit Timischl; Andreas Mackensen; Leoni Kunz-Schughart; Reinhard Andreesen; Stefan W Krause; Marina Kreutz
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

2.  Tamoxifen and estradiol interact with the flavin mononucleotide site of complex I leading to mitochondrial failure.

Authors:  Paula I Moreira; José Custódio; António Moreno; Catarina R Oliveira; Maria S Santos
Journal:  J Biol Chem       Date:  2006-01-12       Impact factor: 5.157

3.  A small molecule inhibitor of ATPase activity of HSP70 induces apoptosis and has antitumor activities.

Authors:  Sung-Kyun Ko; Jiyeon Kim; Deuk Chae Na; Sookil Park; Seong-Hyun Park; Ji Young Hyun; Kyung-Hwa Baek; Nam Doo Kim; Nak-Kyoon Kim; Young Nyun Park; Kiwon Song; Injae Shin
Journal:  Chem Biol       Date:  2015-03-12

Review 4.  Anticancer potential of quercetin: A comprehensive review.

Authors:  Abdur Rauf; Muhammad Imran; Imtiaz Ali Khan; Mujeeb- Ur-Rehman; Syed Amir Gilani; Zaffar Mehmood; Mohammad S Mubarak
Journal:  Phytother Res       Date:  2018-07-24       Impact factor: 5.878

5.  Rational design of mitochondria-targeted pyruvate dehydrogenase kinase 1 inhibitors with improved selectivity and antiproliferative activity.

Authors:  Biao Xu; Zhimei Yu; Sichuan Xiang; Yunshan Li; Shao-Lin Zhang; Yun He
Journal:  Eur J Med Chem       Date:  2018-06-05       Impact factor: 6.514

Review 6.  Fatty acid oxidation: An emerging facet of metabolic transformation in cancer.

Authors:  Yibao Ma; Sarah M Temkin; Adam M Hawkridge; Chunqing Guo; Wei Wang; Xiang-Yang Wang; Xianjun Fang
Journal:  Cancer Lett       Date:  2018-08-10       Impact factor: 8.679

7.  Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.

Authors:  Gang Cheng; Jacek Zielonka; Olivier Ouari; Marcos Lopez; Donna McAllister; Kathleen Boyle; Christy S Barrios; James J Weber; Bryon D Johnson; Micael Hardy; Michael B Dwinell; Balaraman Kalyanaraman
Journal:  Cancer Res       Date:  2016-05-23       Impact factor: 12.701

8.  Mitochondria-Targeting Polydopamine Nanoparticles To Deliver Doxorubicin for Overcoming Drug Resistance.

Authors:  Wen-Qing Li; Zhigang Wang; Sijie Hao; Hongzhang He; Yuan Wan; Chuandong Zhu; Li-Ping Sun; Gong Cheng; Si-Yang Zheng
Journal:  ACS Appl Mater Interfaces       Date:  2017-05-10       Impact factor: 9.229

9.  Mitochondrial Delivery of Phenol Substructure Triggers Mitochondrial Depolarization and Apoptosis of Cancer Cells.

Authors:  Elena Gazzano; Loretta Lazzarato; Barbara Rolando; Joanna Kopecka; Stefano Guglielmo; Costanzo Costamagna; Konstantin Chegaev; Chiara Riganti
Journal:  Front Pharmacol       Date:  2018-06-04       Impact factor: 5.810

10.  Mitochondrial electron transport chain, ROS generation and uncoupling (Review).

Authors:  Ru-Zhou Zhao; Shuai Jiang; Lin Zhang; Zhi-Bin Yu
Journal:  Int J Mol Med       Date:  2019-05-08       Impact factor: 4.101

View more
  7 in total

Review 1.  Targeting Energy Metabolism in Cancer Treatment.

Authors:  Joanna Kubik; Ewelina Humeniuk; Grzegorz Adamczuk; Barbara Madej-Czerwonka; Agnieszka Korga-Plewko
Journal:  Int J Mol Sci       Date:  2022-05-16       Impact factor: 6.208

2.  Chemoprevention of Lung Cancer with a Combination of Mitochondria-Targeted Compounds.

Authors:  Qi Zhang; Donghai Xiong; Jing Pan; Yian Wang; Micael Hardy; Balaraman Kalyanaraman; Ming You
Journal:  Cancers (Basel)       Date:  2022-05-21       Impact factor: 6.575

Review 3.  Carboranes as unique pharmacophores in antitumor medicinal chemistry.

Authors:  Yu Chen; Fukuan Du; Liyao Tang; Jinrun Xu; Yueshui Zhao; Xu Wu; Mingxing Li; Jing Shen; Qinglian Wen; Chi Hin Cho; Zhangang Xiao
Journal:  Mol Ther Oncolytics       Date:  2022-01-10       Impact factor: 7.200

4.  Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria-Targeted Atovaquone.

Authors:  Mofei Huang; Donghai Xiong; Jing Pan; Qi Zhang; Yian Wang; Charles R Myers; Bryon D Johnson; Micael Hardy; Balaraman Kalyanaraman; Ming You
Journal:  Adv Sci (Weinh)       Date:  2022-03-04       Impact factor: 17.521

5.  Synergic Effect of Metformin and Everolimus on Mitochondrial Dynamics of Renal Cell Carcinoma.

Authors:  Seong-Hwi Hong; Kwang-Suk Lee; Hyun-Ji Hwang; Sung-Yul Park; Woong-Kyu Han; Young-Eun Yoon
Journal:  Genes (Basel)       Date:  2022-07-06       Impact factor: 4.141

Review 6.  An Epigenetic Role of Mitochondria in Cancer.

Authors:  Yu'e Liu; Chao Chen; Xinye Wang; Yihong Sun; Jin Zhang; Juxiang Chen; Yufeng Shi
Journal:  Cells       Date:  2022-08-13       Impact factor: 7.666

7.  Curcumin Sensitises Cancerous Kidney Cells to TRAIL Induced Apoptosis via Let-7C Mediated Deregulation of Cell Cycle Proteins and Cellular Metabolism.

Authors:  Ismael Obaidi; Alfonso Blanco Fernández; Tara McMorrow
Journal:  Int J Mol Sci       Date:  2022-08-24       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.